Qiang Wang

Dr. Qiang Wang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
CZCheng Zha
Cheng Zha
ZPZheng Peng
Zheng Peng
KHKunyuan Huang
Kunyuan Huang
KTKaifa Tang
Kaifa Tang
QWQiang Wang
Qiang Wang
WZWenjun Zhang
Wenjun Zhang
The gut microbiota helps to reveal the relationship between diseases, but the role of gut microbiota in prostate cancer (PCa) is still unclear. Recent studies have found that the composition and abundance of specific gut microbiota are significantly different between PCa and non-PCa, and the gut microbiota may have common and unique characteristics between different diseases. Intestinal microorganisms are affected by various factors and interact with the host in a variety of ways. In the complex interaction model, the regulation of intestinal microbial metabolites and the host immune system is particularly important, and they play a key role in maintaining the ecological balance of intestinal microorganisms and metabolites. However, specific changes in the composition of intestinal microflora may promote intestinal mucosal immune imbalance, leading to the formation of tumors. Therefore, this review analyzes the immune regulation of intestinal flora and the production of metabolites, as well as their effects and mechanisms on tumors, and briefly summarizes that specific intestinal flora can play an indirect role in PCa through their metabolites, genes, immunity, and pharmacology, and directly participate in the occurrence, development, and treatment of tumors through bacterial and toxin translocation. We also discussed markers of high risk PCa for intestinal microbiota screening and the possibility of probiotic ingestion and fecal microbiota transplantation, in order to provide better treatment options for clinic patients. Finally, after summarizing a number of studies, we found that changes in immunity, metabolites.

1 December 2023 in Asian Journal of Andrology
Verified
Journal Article
Open access
TLTao Li
Tao Li
YJYi-Ting Jiang
Yi-Ting Jiang
XQXin-Zhu Qi
Xin-Zhu Qi
PCPeng Chen
Peng Chen
JZJun-Hao Zhang
Jun-Hao Zhang
QWQiang Wang
Qiang Wang
In order to explore the impact of circadian disturbance on erectile function, we randomly divided 24 adult male rats into groups of control (light on at 8:00 a.m. and off at 8:00 p.m.), dark/dark (DD; constant dark), light/light (LL; constant light), and shift dark/light (DL; light off at 8:00 a.m. and on at 8:00 p.m.). Four weeks later, erectile function was measured and corpora cavernosa were harvested for analysis. The maximum intracavernous pressure (mICP) and mICP/mean arterial pressure (MAP) ratio in the DD, LL, and DL groups were significantly lower than that in the control group. The LL and DL groups showed significantly attenuated endothelial nitric oxide synthase (eNOS), while DD, LL, and DL showed reduced neuronal nitric oxide synthase (nNOS) at both mRNA and protein levels. The production of nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) was inhibited by altered light/dark cycles to varying degrees. Circadian disturbance impaired endothelial function and contributed to erectile dysfunction. For the core circadian elements, mRNA expression of circadian locomotor output cycles kaput (Clock) and brain/muscle aryl-hydrocarbon receptor nuclear translocator-like protein 1 (Bmal1) was elevated in the DL group, but their protein expression was not significantly changed. DD, LL, and DL increased period 1 (Per1) and Per3 levels, while LL and DL increased PER1 levels. No significant difference was found for Per2 levels, and PER2 and PER3 concentrations were not significantly changed. Moreover, LL and DL significantly increased cryptochrome-1 (CRY1) and CRY2 at both mRNA and protein levels. The altered light/dark rat model showed that circadian disturbance contributed to erectile dysfunction probably by impairing endothelial function. Meanwhile, the core circadian elements were detected in the corpora cavernosa, but these were disrupted. However, which circadian element regulates erectile function and how it works need further analysis.

1 December 2025 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
LHLing-Yu He
Ling-Yu He
BCBo Chen
Bo Chen
XYXiao Yu
Xiao Yu
SXSheng-Han Xu
Sheng-Han Xu
CZCheng Zha
Cheng Zha
WLWei Li
Wei Li
Background: Inflammatory myofibroblastic tumor (IMT) is a relatively rare mesenchymal tumor in clinical practice and is difficult to diagnose. At present, clinical reports on this disease are still relatively scattered. Especially for IMT occurring in special sites such as the nasal cavity, sacrum, and bladder, systematic reports on its clinical manifestations, treatment responses, and prognostic characteristics are still lacking. Case Description: This study retrospectively reported six patients with low-grade IMT diagnosed by pathology (three males and three females), aged 15 to 63 years (with an average age of 41.67 years). The maximum diameter of the tumors ranged from 2.0 to 9.5 cm (with an average of 4.4 cm), and the involved sites included the nasal cavity, upper limbs, chest wall, sacrum, and bladder. All patients underwent surgical treatment and were followed up for 13 to 33 months after the operation (with an average of 19.67 months). Among them, one patient with nasal IMT had local recurrence after the operation, one patient with sacral IMT was found to have multiple bone metastases throughout the body during the follow-up period, and no recurrence or metastasis was observed in the remaining four cases. Conclusions: IMT is a tumor with “low malignant potential” or “borderline” characteristics. It is neither a typical benign tumor nor a highly malignant cancer, but occupies an intermediate gray zone. It can occur at multiple sites in the body, most commonly in the lungs, and has been reported across all age groups. Through the analysis of six cases of IMT with unusual primary sites, this study found that even with low-grade pathological features, the tumor can still exhibit aggressive biological behavior, including postoperative recurrence and distant metastasis, when arising in atypical locations such as the sacrum or nasal cavity. This suggests that the clinical management of IMT should not rely solely on pathological grading but should also involve a comprehensive evaluation incorporating the tumor’s location and size. This case series contributes to broadening the understanding of the clinical spectrum of IMT, enhances awareness of IMT in rare sites, and provides important clinical rationale for long-term systematic follow-up and monitoring for all patients with IMT.

19 November 2025 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
PDF file
XZXiong Zou
Xiong Zou
YLYanfeng Li
Yanfeng Li
XPXuefeng Peng
Xuefeng Peng
CGChangshi Gu
Changshi Gu
QWQiang Wang
Qiang Wang
Background: The heterogeneous prognosis of bladder urothelial carcinoma (BLCA) remains a significant clinical challenge. A multi-factor prognostic model is essential for BLCA, as it not only assesses tumor progression and elucidates underlying molecular mechanisms but also paves the way for timely treatment adjustments and improved clinical decision-making. Methods: Using R software, we performed immunophenotyping on multiple BLCA cohorts from the GEO database to identify shared immune signatures. Simultaneously, we identified BLCA prognosis-associated genes by analyzing TCGA data. Prognostic genes were further refined via LASSO regression, allowing BLCA patients to be stratified into high- and low-risk groups based on their expression patterns. Quantitative PCR (qPCR) was used to validate gene expression in tumor and matched normal tissues. Finally, we integrated clinical data to construct a prognostic model. Results: The GSE31684 and GSE48276 cohorts were divided into high immunity (Immunity_H) and low immunity (Immunity_L) groups, and there were significant microenvironment differences between the Immunity_H and Immunity_L of the two cohorts, and there were many common differentially expressed genes (DEGs) between different immune subtypes of the two cohorts, which were mainly involved in immune-related biological processes. In addition, patients in the high-risk BLCA group exhibited significantly worse prognosis than those in the low-risk group. qPCR analysis confirmed that the expression levels of the risk-stratification genes were significantly different between BLCA tumors and matched adjacent normal tissues. The integrated analysis of tumor mutation burden (TMB) and our risk stratification revealed that patients with low-risk scores and high TMB exhibited the most favorable prognosis. Furthermore, the risk score was validated as an independent prognostic factor through both univariate and multivariate Cox regression analyses. Consequently, we constructed a nomogram that incorporates these findings to assist clinicians in prognostic assessment for BLCA patients. Conclusion: Given that the tumor microenvironment significantly influences BLCA prognosis, our finding that risk stratification serves as an independent prognostic indicator underscores the clinical relevance of our model. This stratification strategy has the potential to improve prognostic assessment and inform personalized treatment planning for BLCA patients.

9 April 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
XPXuefeng Peng
Xuefeng Peng
QWQiang Wang
Qiang Wang
This study reports the case of a 67-year-old man with scrotal Paget’s disease. A systematic analysis of the clinical features, diagnostic and therapeutic strategies, and prognosis management of this rare disease was performed in conjunction with a literature review. The patient had a prolonged disease course with a history of three previous lesion excisions and presented this time due to lesion enlargement accompanied by mucous discharge. Dermoscopic examination revealed a “red background with punctate vessels,” and preoperative epidermal histopathology supported the diagnosis of Paget’s disease. The surgical approach involved wide excision of the lesion, aiming to remove the lesion as completely as possible while preserving the morphology and function of the surrounding tissues. Intraoperative frozen section analysis showed positive margins at the 1, 2, 6, and 11 o’clock positions. After further excision, immunohistochemical staining confirmed cytokeratin 7 (CK7) (+), gross cystic disease fluid protein-15 (GCDFP-15) (+), consistent with a sweat gland origin, and podoplanin (D2-40) (+), indicating a potential risk of lymphatic invasion. Finally, the patient was followed up regularly as planned, and at the most recent follow-up, no signs of recurrence were observed, and treatment outcomes were satisfactory, thereby allowing the discontinuation of further follow-up examinations. This case report provides a valuable practical reference for the standardized diagnosis and treatment of this rare condition.

22 June 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
YLYue Li
Yue Li
XPXuefeng Peng
Xuefeng Peng
SJSuiyang Jin
Suiyang Jin
QWQiang Wang
Qiang Wang
Primary mucinous adenocarcinoma of the bladder is a rare and highly aggressive malignancy. Its diagnosis is challenging due to the need to exclude metastatic gastrointestinal adenocarcinoma, and standardized treatment protocols are lacking. Here, we report a case of primary bladder mucinous adenocarcinoma in a 70-year-old female who presented with urinary difficulty without hematuria. The diagnostic workup integrated endoscopic evaluation with immunohistochemical markers (CK7–, CK20+, CDX-2+, β-catenin membrane+, SATB2–, GATA3–) to rule out a colorectal primary. The patient underwent transurethral resection followed by robot-assisted radical cystectomy (pT4aN0M0) but declined adjuvant therapy for personal reasons. At 6-month follow-up, no recurrence or metastasis was detected. This case highlights the diagnostic utility of a targeted immunohistochemical panel, the real-world complexity of treatment decisions in the absence of guidelines, and is compared with all reported cases from the past decade in a structured literature review.